Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Human Papillomavirus Vaccines
Data on human papillomavirus vaccines discussed by researchers at Chung-Ang University, College of Pharmacy
April 15th, 2008
A report, 'Expression and purification of human papillomavirus 18 L1 virus-like particle from saccharomyces cerevisiae,' is newly published data in Archives of Pharmacal Research. According to a study from Seoul, Korea, "Cervical cancer caused by human papillomavirus (HPV) might be successfully prevented by HPV vaccination and screening. HPV vaccination and HPV serology assays have been investigated using HPV virus-like particles (VLPs)." "In this study we produced HPV18 L1 VLPs in Saccharomyces cerevisiae and purified them. The HPV18 L1 gene was cloned into the yeast expression vector YEGalpha-HIR525, and transformed into Saccharomyces cerevisiae....
Source: Cancer Weekly (2008-04-15)
|
